Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
29 participants
INTERVENTIONAL
2012-10-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pet Ownership and Glucose Control in Early Adolescents With Type 1 Diabetes
NCT03761251
Impact of Integrated Pet Care on Glycemic Control and Diabetes Responsibility
NCT06598345
Home-Based Interventions for Adolescents With Type 1 Diabetes
NCT02243072
Ability to Cope With Type 1 Diabetes
NCT00206362
A Survey To Elicit The Relationship Between Literacy And Glycemic Control In Pediatric Diabetes
NCT00717223
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Current standards for diabetes management reflect the need to maintain glucose control within a normal range. However, numerous reports indicate that normalization of blood glucose levels is seldom attainable in children and adolescents. Family cohesion, positive coping strategies, younger age of onset, social support and adequate self-regulatory behavior are found to favorably influence glycemic control. One may conclude that the presence of a companion animal, capable of enhancing the positive factors named above, would augment the array of tools available for the successful management of chronic illnesses such as T1DM.
There is a lack of studies assessing the impact of pet ownership on the health and well-being of adolescents. The process of caring for, loving and being loved by a companion animal could offer direct and/or indirect benefits to the HRQoL in children with T1DM. To the investigators' knowledge, there are no studies examining the impact of pet ownership on glycemic control and HRQoL in youth with T1DM.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Picture of a fish
Participants will receive a picture of a betta fish.
Picture of a fish
Participants will receive a picture of a betta fish.
Pet fish
Participants will receive a betta fish and the supplies to care for the fish for a one year time period.
Pet Fish
Participants will receive a betta fish and the supplies to care for the fish for a one year time period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pet Fish
Participants will receive a betta fish and the supplies to care for the fish for a one year time period.
Picture of a fish
Participants will receive a picture of a betta fish.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 10 to 18 years
* diagnosed with type 1 diabetes for at least 12 months
* poor diabetes control as defined by having a hemoglobin A1c value \> 8%
Exclusion Criteria
* developmental delay
* current participation in another study that may impact glycemic control
10 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Massachusetts, Worcester
OTHER
University of Texas Southwestern Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Olga Gupta
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olga T Gupta, MD
Role: PRINCIPAL_INVESTIGATOR
UT Southwestern
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Texas Southwestern Medical Center
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.